India · Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 111.27 billion. The enterprise value is 123.99 billion.
| Market Cap | 111.27B |
| Enterprise Value | 123.99B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 149.30 million shares outstanding. The number of shares has increased by 2.50% in one year.
| Current Share Class | 149.30M |
| Shares Outstanding | 149.30M |
| Shares Change (YoY) | +2.50% |
| Shares Change (QoQ) | +3.46% |
| Owned by Insiders (%) | 9.41% |
| Owned by Institutions (%) | 17.67% |
| Float | 59.34M |
Valuation Ratios
The trailing PE ratio is 488.44 and the forward PE ratio is 68.74. NSE:HCG's PEG ratio is 0.84.
| PE Ratio | 488.44 |
| Forward PE | 68.74 |
| PS Ratio | 4.23 |
| PB Ratio | 7.89 |
| P/TBV Ratio | 12.21 |
| P/FCF Ratio | 202.30 |
| P/OCF Ratio | 32.06 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.96, with an EV/FCF ratio of 225.44.
| EV / Earnings | 544.31 |
| EV / Sales | 4.72 |
| EV / EBITDA | 24.96 |
| EV / EBIT | 55.04 |
| EV / FCF | 225.44 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 3.51 |
| Debt / FCF | 31.55 |
| Interest Coverage | 1.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.13% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.60% |
| Revenue Per Employee | 3.90M |
| Profits Per Employee | 33,818 |
| Employee Count | 6,736 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:HCG has paid 67.70 million in taxes.
| Income Tax | 67.70M |
| Effective Tax Rate | 16.91% |
Stock Price Statistics
The stock price has increased by +9.55% in the last 52 weeks. The beta is -0.04, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +9.55% |
| 50-Day Moving Average | 662.65 |
| 200-Day Moving Average | 639.51 |
| Relative Strength Index (RSI) | 63.73 |
| Average Volume (20 Days) | 185,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 26.27 billion and earned 227.80 million in profits. Earnings per share was 1.57.
| Revenue | 26.27B |
| Gross Profit | 9.59B |
| Operating Income | 2.24B |
| Pretax Income | 400.30M |
| Net Income | 227.80M |
| EBITDA | 4.95B |
| EBIT | 2.24B |
| Earnings Per Share (EPS) | 1.57 |
Balance Sheet
The company has 5.41 billion in cash and 17.35 billion in debt, with a net cash position of -11.94 billion or -80.00 per share.
| Cash & Cash Equivalents | 5.41B |
| Total Debt | 17.35B |
| Net Cash | -11.94B |
| Net Cash Per Share | -80.00 |
| Equity (Book Value) | 14.10B |
| Book Value Per Share | 92.07 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 3.47 billion and capital expenditures -2.92 billion, giving a free cash flow of 550.00 million.
| Operating Cash Flow | 3.47B |
| Capital Expenditures | -2.92B |
| Depreciation & Amortization | 2.71B |
| Net Borrowing | -369.60M |
| Free Cash Flow | 550.00M |
| FCF Per Share | 3.68 |
Margins
Gross margin is 36.51%, with operating and profit margins of 8.51% and 0.87%.
| Gross Margin | 36.51% |
| Operating Margin | 8.51% |
| Pretax Margin | 1.52% |
| Profit Margin | 0.87% |
| EBITDA Margin | 18.84% |
| EBIT Margin | 8.51% |
| FCF Margin | 2.16% |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.50% |
| Shareholder Yield | -2.50% |
| Earnings Yield | 0.20% |
| FCF Yield | 0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:HCG is 800.60, which is 9.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 800.60 |
| Price Target Difference | 9.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 15.47% |
| EPS Growth Forecast (3Y) | 87.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |